In seroepidemiological studies, the most popular antibodies are those against the blood-stage apical membrane antigen-1 (AMA1) and merozoite surface protein-1 (MSP1) [7, 8, 13–16] owing to their broad immunogenicity and putative role in malaria vaccine development [17, 18]. Here, ATAD1 is linked to malaria.